Heartflow (HTFL) EBITDA (2024 - 2025)
Heartflow (HTFL) recorded quarterly EBITDA of -$24.3 million in Q4 2025, up 52.01% quarter-over-quarter from -$50.6 million in Q3 2025, and up 25.76% on a YoY basis from -$19.3 million in Q4 2024.
Heartflow (HTFL) EBITDA (2024 - 2025) Analysis & Trends
Heartflow's EBITDA history runs 2 years deep, the most recent figure standing at -$24.3 million for Q4 2025.
- In Q4 2025, EBITDA rose 25.76% year-over-year to -$24.3 million; the TTM figure through Dec 2025 stood at -$116.6 million (changed N/A YoY), while the FY2025 annual figure was -$116.4 million, down 20.42% from the prior year.
- EBITDA was -$24.3 million for Q4 2025 at Heartflow, up from -$50.6 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$8.9 million in Q2 2025 to a low of -$50.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 232.98 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 121.45 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 102.95 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 34.80 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -17.05 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 24.83 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 87.47 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 7.57 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 16.85 Mn |
| 10 | Heartflow | 1.24 Bn | 1.06 Bn | 39.06 Mn | -24.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -24.31 Mn |
| Sep 30, 2025 | -50.65 Mn |
| Jun 30, 2025 | -8.91 Mn |
| Dec 31, 2024 | -32.74 Mn |
| Sep 30, 2024 | -19.55 Mn |
| Jun 30, 2024 | -23.48 Mn |